|Participants wanted for a study on treating symptoms of complex|
trauma disorder (aka borderline personality disorder)
Early life trauma is causally implicated in borderline personality disorder (BPD) and there is strong support for the notion that BPD overlaps clinically with disorders of complex post-traumatic stress.
Some hallmark features of BPD are fluctuating instability in self-image, interpersonal relationships, and emotions. Many individuals with BPD have intense fears of abandonment, oscillate between idealizing and angrily devaluing others, and engage in deliberate self-harm including self-mutilation, suicide attempts and abuse of alcohol and drugs. As a result, CTD is a highly prevalent complex psychiatric disorder with high morbidity and mortality. Thus, this randomised double-blind placebo trial aims to investigate the use of a noncompetitive NMDA antagonist, memantine, in treating behavioural and cognitive symptoms of CTD.
|Prof Jayashri Kulkarni, study lead|
Contact: Miss Iris Liang
Phone: (03) 9076 6589
Ethics Committee Project Number: 204/11